Dopaminergic system genes in ADHD: Toward a biological hypothesis

Neuropsychopharmacology

Volumn 27, Issue 4, 2002, Pages 607-619

  Kirley, Aiveen ^a,b   Hawi, Ziarih ^a   Daly, Grainne ^a   McCarron, Mary ^a   Mullins, Celine ^a   Millar, Niamh ^a   Waldman, Irwin ^a   Fitzgerald, Michael ^a   Gill, Michael ^a  

^a TRINITY COLLEGE DUBLIN   (Ireland)

^b ST JAMES S HOSPITAL   (Ireland)

Author keywords

Attention deficit hyperactivity disorder; Candidate genes; Dopamine receptors; Dopamine transporter; Haplotype based haplotype relative risk; Imprinting; Transmission Disequilibrium Test

Indexed keywords

AROMATIC LEVO AMINO ACID DECARBOXYLASE; CATECHOL METHYLTRANSFERASE; DOPA; DOPAMINE; DOPAMINE RECEPTOR; DOPAMINE TRANSPORTER; PROTEIN; PROTEIN DAT1; PROTEIN DBH; PROTEIN DRD1; PROTEIN DRD2; PROTEIN DRD3; PROTEIN DRD4; PROTEIN DRD5; UNCLASSIFIED DRUG;

ADOLESCENT; ALLELE; ARTICLE; ATTENTION DEFICIT DISORDER; CHILD; CONTROLLED STUDY; DISEASE PREDISPOSITION; DNA POLYMORPHISM; DOPAMINE METABOLISM; DOPAMINERGIC SYSTEM; EXON; GENE AMPLIFICATION; GENE DELETION; GENE LOCUS; HUMAN; MAJOR CLINICAL STUDY; MOLECULAR GENETICS; NEUROTRANSMISSION; PRIORITY JOURNAL; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; SYNAPSE;

ADOLESCENT; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; BRAIN; CHILD; CHILD, PRESCHOOL; DNA MUTATIONAL ANALYSIS; DOPAMINE; DOPAMINE PLASMA MEMBRANE TRANSPORT PROTEINS; FEMALE; GENE DELETION; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENETIC SCREENING; HUMANS; INHERITANCE PATTERNS; MALE; MEMBRANE GLYCOPROTEINS; MEMBRANE TRANSPORT PROTEINS; MUTATION; NERVE TISSUE PROTEINS; NEURAL PATHWAYS; POLYMORPHISM, GENETIC; RECEPTORS, DOPAMINE; SEX FACTORS;

EID: 0036788707     PISSN: 0893133X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0893-133X(02)00315-9     Document Type: Article

References (119)

1. Alberts-Corush J., Firestone P., Goodman J.T. Attention and impulsivity characteristics of the biological and adoptive parents of hyperactive and normal control children. Am J Orthopsychiatry. 56:1986;413-423.
2. Amara S., Kuhar M. Neurotransmitter transporters. recent progress Ann Rev Neurosci. 16:1993;73-93.
3. Anden M.E., Atack C.V., Svensen T.H. Release of dopamine from central noradrenaline and dopamine nerves by a dopamine β-hydroxylase inhibitor. J Neural Transm. 34:1973;93-100.
4. Anderson J.C., Williams S., McGee R., Silva P.A. DSM-III-R disorders in preadolescent children. prevalence in a large sample from the general population Arch Gen Psychiatry. 44:1987;69-76.
5. Asherson P., Virdee V., Curran S., Ebersole L., Freeman B., Craig I., Simonson E., Eley T., Plomin R., Taylor E. Association study of DSM IV attention -deficit hyperactivity disorder (ADHD) and monoamine pathway genes. Am J Med Genet Neuropsychiatr Genet. 81:1998;549.
6. Ashgari V., Sanyal S., Buchwaldt S. Modulation of intracellular cyclic AMP levels by different human dopamine D4 receptor variants. J Neurochem. 65:1995;1157-1165.
7. Axelrod J., Weinshilboum R.M. Catecholamines. N Engl J Med. 287:1972;237-242.
8. Baik J.H., Picetti R., Saiardi A., Thiriet G., Dierich A., Depaulis A., Le Meur M., Borrelli E. Parkinsonian-like locomotor impairment in mice lacking dopamine D2 receptors. Nature. 377(6548):1995;424-428.
9. Barkley R.A. Attention Deficit Hyperactivity Disorder. A Handbook for Diagnosis and Treatment:1990;Guilford, New York.
10. Barr C.L., Wigg K., Malone M., Schachar R., Tannock R., Roberts W., Kennedy J.L. Linkage study of catechol-O-methyltransferase and attention-deficit hyperactivity disorder. Am J Med Genet. 88(6):1999;710-713.
11. Barr C.L., Wigg K.G., Feng Y., Zai G., Malone M., Roberts W., Schachar R., Tannock R., Kennedy J.L. Attention-deficit hyperactivity disorder and the gene for the dopamine D5 receptor. Mol Psychiatry. 5:2000;548-551. a.
12. Barr C.L., Wigg K.G., Wu J., Zai C., Bloom S., Tannock R., Roberts W., Malone M., Schachar R., Kennedy J.L. Linkage study of two polymorphisms at the dopamine D3 receptor gene and attention-deficit hyperactivity disorder. Am J Med Genet Neuropsychiatr Genetics. 96:2000;114-117. b.
13. Barr C.L., Wigg K.G., Bloom S., Schachar R., Tannock R., Roberts W., Malone M., Kennedy J.L. Further evidence from haplotype analysis for linkage of the dopamine D4 receptor gene and attention-deficit hyperactivity disorder. Am J Med Genet. 96(3):2000;262-267. c.
14. Barr C.L., Feng Y., Wigg K., Roberts W., Malone M., Schachar R., Tannock R., Kennedy J.L. Identification of DNA variants in the SNAP-25 gene and linkage study of these polymorphisms and attention-deficit hyperactivity disorder. Mol Psychiatry. 5:2000;405-409. d.
15. Barr C.L., Xu C., Kroft J., Feng Y., Wigg K., Zai G., Tannock R., Schacher R., Malone M., Roberts W., Nothen M.M., Grunhage F., Vandenburgh D.J., Uhl G., Sunohara G., King N., Kennedy J.L. Haplotype study of three polymorphisms at the dopamine transporter locus confirm linkage to attention-deficit/hyperactivity disorder. Biol Psychiatry. 49:2001;333-339.
16. Baumgartel A., Wolraich M.L., Dietrich M. Comparison of diagnostic criteria for attention deficit disorders in a German elementary school sample. J Am Acad of Child Adolesc Psychiatry. 34:1995;629-638.
17. Benjamin J., Patterson C., Greenberg B.D. Population and familial association between the D4 dopamine receptor gene and measures of novelty seeking. Nat Genet. 12:1996;81-84.
18. Biederman J., Faraone S.V., Keenan K., Knee D., Tsuang M.T. Family-genetic and psychosocial risk factors in DSM-III attention deficit disorder. J Am Acad Child Adolesc Psychiatry. 29(4):1990;526-533.
19. Biederman J., Faraone S.V., Keenan K., Benjamin J., Krifcher B., Moore C., Sprich-Buckminster S., Ugaglia K., Jellinek M.S., Steingard R., Spencer T., Norman D., Kolodny R., Kraus I., Perrin J., Keller M.B., Tsuang M.T. Further evidence for family-genetic risk factors in attention deficit hyperactivity disorder patterns of comorbidity in probands and relatives in psychiatrically and paediatrically referred samples. Arch Gen Psychiatry. 49:1992;728-738.
20. Cadoret R.J., Stewart M.A. An adoption study of ADH/D and aggression and their relationship to adult antisocial personality. Comp Psychiatry. 32:1991;73-82.
21. Castellanos F.X. Toward a pathophysiology of attention-deficit/hyperactivity disorder. Clin Paediatr. 36:1997;381-393.
22. Castellanos F.X., Lau E., Tayebi N., Lee P., Long R.E., Giedd J.N., Sharp W., Marsh W.L., Walter J.M., Hamburger S.D., Ginns E.L., Rapoport J.L., Sidransky E. Lack of association between a dopamine-4 receptor polymorphism and attention deficit hyperactivity disorder. genetic and brain morphometric analyses Mol Psychiatry. 3:1998;431-434.
23. Cichon S., Nothen M.M., Stober G., Schroers R., Albus M., Maier W., Rietschel M., Korner J., Weigelt B., Franzek E., Wildenauer D., Fimmers R., Propping P. Systematic screening for mutations in the 5′-regulatory region of the human dopamine D1 receptor (DRD1) gene in patients with schizophrenia and bipolar affective disorder. Am J Med Genet. 67(4):1996;424-428.
24. Comings D.E., Comings B.G., Muhleman D., Dietz G., Shahbahrami B., Tast D., Kocsis P., Baumgarten R., Kovacs B.W., Levy D.L., Smith M., Borison R.L., Evans D.D., Klein D.N., MacMurray J., Tosk J.M., Sverd J., Gysin R., Flanagan S.D. The dopamine D2 receptor locus as a modifying gene in neuropsychiatric disorders. JAMA. 266(13):1991;1793-1800.
25. Comings D.E., Wu S., Chiu C., Ring R.H., Gade R., Ahn C., MacMurray J.P., Dietz G., Muhleman D. Polygenic inheritance of Tourette syndrome, stuttering, attention deficit hyperactivity, conduct and oppositional defiant disorder. the additive and subtractive effect of the three dopaminergic genes-DRD2, DBH, and DAT1 Am J Med Genet. 67:1996;264-288.
26. Comings D.E., Gonzalez N., Wu S., Gade R., Muhleman D., Saucier G., Johnson P., Verde R., Rosenthal R.J., Lesieur H.R., Rugle L.J., Miller W.B., MacMurray J.P. Studies of the 48 bp repeat polymorphism of the DRD4 gene in impulsive, compulsive, addictive behaviors. Tourette syndrome, ADHD, pathological gambling, and substance abuse Am J Med Genet. 88(4):1999;358-368.
27. Cook E.H., Stein M.A., Krasowski M.D., Cox N.J., Olkon D.M., Kieffer J.E., Leventhal B.L. Association of attention-deficit disorder and the dopamine transporter gene. Am J Hum Genet. 56:1995;993-998.
28. Craig S.P., Buckle V.J., Lamouroux A., Mallet J., Craig I. Localization of the human tyrosine hydroxylase gene to 11p15. gene duplication and evolution of metabolic pathways Cytogenet Cell Genet. 42(1-2):1986;29-32.
29. Cubells J.F., van Kammen D.P., Kelley M.E., Anderson G.M., O'Connor D.T., Price L.H., Malison R., Rao P.A., Kobayashi K., Nagatsu T., Gelernter J. Dopamine β-hydroxylase. two polymorphisms in linkage disequilibrium at the structural gene DBH associate with biochemical phenotypic variation Hum Genet. 102:1998;533-540.
30. Curran S., Mill J., Tahir E., Kent L., Richards S., Gould A., Huckett L., Sharp J., Batten C., Fernando S., Ozbay F., Yazgan Y., Simonoff E., Thompson M., Taylor E., Asherson P. Association study of a dopamine transporter polymorphism and attention deficit hyperactivity disorder in UK and Turkish samples. Mol Psychiatry. 6(4):2001;425-428.
31. Daly G., Hawi Z., Fitzgerald M., Gill M. Mapping susceptibility loci in attention deficit hyperactivity disorder. Preferential transmission of parental alleles at DAT1, DBH and DRD5 to affected children Mol Psychiatry. 4:1999;192-196.
32. Deutsch C.K., Mattyse S., Swanson J.M., Farkas L.G. Genetic latent structure analysis of dysmorphology in attention deficit disorder. J Am Acad Child Adolesc Psychiatry. 29(2):1990;189-194.
33. de Villiers A.S., Russell V.A., Sagvolden T., Searson T., Searson A., Jaffer A., Taljaard J.J. Alpha 2-adrenoceptor mediated inhibition of [3H]dopamine release from nucleus accumbens slices and monoamine levels in a rat model for attention-deficit hyperactivity disorder. Neurochem Res. 20(4):1995;427-433.
34. Dickinson S.D., Sabeti J., Larson G.A., Giardina K., Rubinstein M., Kelly M.A., Grandy D.K., Low M.J., Gerhardt G.A., Zahniser N.R. Dopamine D2 receptor-deficient mice exhibit decreased dopamine transporter function but no changes in dopamine release in dorsal striatum. J Neurochem. 72(1):1999;148-156.
35. Dougherty D.D., Bonab A.A., Spencer T.J., Rauch S.L., Madras B.K., Fischman A.J. Dopamine transporter density in patients with attention deficit hyperactivity disorder. Lancet. 354(9196):1999;2132-2133.
36. Elia J., Borcherding B.G., Potter W.Z., Mefford I.N., Rapoport J.L., Keysor C.S. Stimulant drug treatment of hyperactivity. biochemical correlates Clin Pharmacol Ther. 48:1990;57-66.
37. Eisenberg J., Mei-Tal G., Steinberg A., Tartakovsky E., Zohar A., Gritsenko I., Nemanov L., Ebstein R.P. A haplotype relative risk study of catechol-O-methyltransferase (COMT) and attention deficit hyperactivity disorder (ADHD). association of the high-enzyme activity Val allele with ADHD impulsive-hyperactive phenotype Am J Med Genet. 88(5):1999;497-502.
38. Eisenberg J., Zohar A., Mei-Tal G. A haplotype relative risk study of the dopamine D4 (DRD4) exon III repeat polymorphism and attention deficit hyperactivity disorder (ADHD). Am J Med Genet. 96:2000;258-261.
39. Ebstein J., Zohar A., Mei-Tal G. Dopamine D4 receptor (D4DR) exon III polymorphism associated with the human personality trait of novelty seeking. Nat Genet. 12:1996;78-80.
40. Ernst M., Zametkin A.J., Matochik J.A., Jons P.H., Cohen R.M. DOPA decarboxylase activity in attention deficit hyperactivity disorder adults. A (Fluorine-18) fluorodopa positron emission tomographic study. J Neurosci. 18(15):1998;5901-5907.
41. Ernst M., Zametkin A.J., Matochik J.A., Pascualvaca D., Jons P.H., Cohen R.M. High midbrain (18F)DOPA accumulation in children with attention deficit hyperactivity disorder. Am J Psychiatry. 156(8):1999;1209-1215.
42. Faraone S., Biederman J., Chen W.J., Krifcher B., Keenan K., Moore C., Sprich S., Tsuang M. Segregation analysis of attention deficit hyperactivity disorder. evidence for single gene transmission Psychiat Genet. 2:1992;257-275.
43. Faraone S.V., Biederman J., Milberger S. An exploratory study of ADHD among second-degree relatives of ADHD children. Biol Psychiatry. 35:1994;398-402.
44. Faraone S.V., Biederman J., Weiffenbach B., Keith T., Chu M.P., Weaver A., Spencer T.J., Wilens T.E., Frazier J., Cleves M., Sakai J. Dopamine D4 gene 7-repeat allele and attention deficit hyperactivity disorder. Am J Psychiatry. 156(5):1999;768-770.
45. Faraone S.V., Doyle A.E., Mick E., Biederman J. Meta-analysis of the association between the dopamine D4 7-repeat allele and attention deficit hyperactivity disorder. Am J Psychiatry. 158(7):2001;1052-1057.
46. Faraone S.V., Biederman J. Pathophysiology of Attention Deficit Hyperactivity Disorder. Davis K., Charney D., Coyle J.T., Nemeroff C. ACNP's Fifth Generation of Progress - Version 2. 2002;Li, New York. oncott, Williams, and Wilkens.
47. Fuke S., Suo S., Takahashi N., Koike H., Sasagawa N., Ishiura S. The VNTR polymorphism of the human dopamine transporter (DAT1) gene affects gene expression. The Pharmacogenomics Journal. 1:2001;152-156.
48. Gainetdinov R.R., Wetsel W.C., Jones S.R., Levin E.D., Jaber M., Caron M.G. Role of serotonin in the paradoxical calming effect of psychostimulants on hyperactivity. Science. 83(5400):1999;397-401.
49. Garfinkel B.D., Wender P.H. Attention deficit hyperactivity disorder. Kaplan H.I., Sadock B.J. Comprehensive Textbook of Psychiatry. 1989;1831 Williams and Wilkins, Baltimore.
50. Gill M., Daly G., Heron S., Hawi Z., Fitzgerald M. Confirmation of association between attention deficit hyperactivity disorder and a dopamine transporter polymorphism. Mol Psychiatry. 2:1997;311-313.
51. Giros B., Jaber M., Jones S., Wightman R.M., Caron M. Hyperlocomotion and indifference to cocaine and amphetamine in mice lacking the dopamine transporter. Nature. 379:1996;606-612.
52. Gittelman R., Mannuzza S., Shenker R., Bonagura N. Hyperactive boys almost grown up. I. Psychiatric status. Arch Gen Psychiatry. 42:1985;937-947.
53. Gjone H., Stevenson J., Sundet J.M. Genetic influence on parent-reported attention related problems in Norwegian general population twin sample. J Am Acad Child and Adoles Psychiatry. 35:1996;588-596.
54. Grandy D.K., Litt M., Allen L. The human dopamine D2 receptor gene is located on chromosome 11 at q22-q23 and identified a Taq 1 RFLP. Am J Hum Genet. 45:1989;778-785.
55. Hawi Z., McCabe U., Straub R.E., O'Neill A., Kendler K.S., Walsh D., Gill M. Examination of new and reported data of the DRD3/MscI polymorphism. no support for the proposed association with schizophrenia Mol Psychiatry. 3(2):1998;150-155.
56. Hawi Z., McCarron M., Kirley A., Fitzgerald M., Gill M. No association of the dopamine DRD4 receptor with attention deficit hyperactivity disorder (ADHD) in the Irish population. Am J Med Genet Neuropsychiatr Genet. 96:2000;268-272. a.
57. Hawi Z., Millar N., Daly G., Fitzgerald M., Gill M. No association between Catechol-O-methyltransferase (COMT) gene polymorphism and attention deficit hyperactivity disorder (ADHD) in an Irish sample. Am J Med Genet Neuropsychiatr Genet. 96:2000;282-284. b.
58. Hawi Z., Brophy K., Kirley A., Fitzgerald M., Gill M. Synaptosomal-associated protein 25 (SNAP-25) and attention deficit hyperactivity disorder (ADHD). evidence of linkage and association in the Irish population Mol Psychiatry. In Press:2001.
59. Hess E.J., Rogan P.K., Domoto M., Tinker D.E., Ladda R.L., Ramer J.C. Absence of linkage of apparently single gene mediated ADHD with the human syntenic region of the mouse mutant Coloboma. Am J Med Genet. 60(6):1995;573-579.
60. Heinz A., Goldman D., Jones D.W., Palmour R., Hommer D., Gorey J.G., Lee K.S., Linnoila M., Weinberger D.R. Genotype influences In Vivo dopamine transporter availability in human striatum. Neuropsychopharmacology. 22(2):2000;133-139.
61. Holmes J., Payton A., Barrett J.H., Hever T., Fitzpatrick H., Trumper A.L., Harrington R., McGuffin P., Owen M., Ollier W., Worthington J., Thapar A. Family-based and case control association study of the dopamine D4 receptor gene and dopamine transporter gene in attention deficit hyperactivity disorder. Mol Psychiatry. 5:2000;523-530.
62. Jaber M., Dumartin B., Sagne C., Haycock J.W., Roubert C., Giros B., Bloch B., Caron M.G. Differential regulation of tyrosine hydroxylase in the basal ganglia of mice lacking the dopamine transporter. Eur J Neurosci. 11(10):1999;3499-3511.
63. Jiang S., Xin R., Wu X., Lin S., Qian Y., Ren D., Tang G., Wang D. Association between attention deficit hyperactivity disorder and the DXS7 locus. Am J Med Genet. 96(3):2000;289-292.
64. Jiang S., Xin R., Qian Y., Lin S., Li F., Wu X., Wang D., Tang G., Jiang K. Study of susceptibility loci located within Xp11 in attention deficit hyperactivity disorder. Zhonghua Yi Xue Za Zhi. 18(3):2001;169-172.
65. King J.A., Barkley R.A., Delville Y., Ferris C.F. Early androgen treatment decreases cognitive function and catecholamine innervation in an animal model of ADHD. Behav Brain Res. 107(1-2):2000;35-43.
66. Kotler M., Manor I., Sever Y., Eisenberg J., Cohen H., Ebstein R.P., Tyano S. Failure to replicate an excess of the long dopamine D4 exon III repeat polymorphism in ADHD in a family-based study. Am J Med Genet. 96(3):2000;278-281.
67. Krause K.L., Dresel S.H., Krause J., Kung H.F., Tatsch K. Increased striatal dopamine transporter in adult patients with attention deficit hyperactivity disorder. effects of methylphenidate as measured by single photon emission computed tomography Neurosci Lett. 285:2000;107-110.
68. LaHoste G.L., Swanson J.M., Wigal S.B., Glabe C., Wigal T., King N., Kennedy J.L. Dopamine D4 receptor gene polymorphism is associated with attention deficit hyperactivity disorder. Mol Psychiatry. 1:1996;121-124.
69. Lee M.P., Brandenburg S., Landes G.M., Adams M., Miller G., Feinberg A.P. Two novel genes in the centre of the 11p15 imprinted domain escape genomic imprinting. Hum Mol Genet. 8(4):1999;683-690.
70. Levy F., Hat D.A., McStephen M., Wood C. Attention deficit hyperactivity disorder. a category or continuum? Genetic analysis of a large-scale twin study J Am Acad Child and Adoles Psychiatry. 36:1997;737-744.
71. Lou H.C., Henriksen L., Bruhn P. Focal cerebral dysfunction in developmental learning disabilities. Lancet. 335:1990;8-11.
72. Lowe N., Hawi Z., Fitzgerald M., Gill M. Letter to the editor. no evidence of linkage or association between ADHD and DXS7 locus in Irish population Am J Med Genet. 105:2001;394-395.
73. Manor I., Kotler M., Sever Y., Eisenberg J., Cohen H., Ebstein R.P., Tyano S. Failure to replicate an association between the catechol-O-methyltransferase polymorphism and attention deficit hyperactivity disorder in a second, independently recruited Israeli cohort. Am J Med Genet. 96(6):2000;858-860.
74. Michaelhaugh S.K., Fiskerstrand C., Lovejoy E., Bannon M.J., Quinn J.P. The dopamine transport gene (SLC6A3) variable number of tandem repeats domain enhances transcription in dopamine neurons. J Neurochem. 79:2001;1033-1038.
75. Mill J., Curran S., Kent L., Richards S., Gould A., Virdee A., Huckett L., Sharp J., Batten C., Fernando S., Simonoff E., Thompson M., Zhao J., Sham P., Taylor E., Asherson P. Attention deficit hyperactivity disorder (ADHD) and the dopamine D4 receptor gene. evidence of association but no linkage in a UK sample Mol Psychiatry. 6(4):2001;440-444.
76. Morrison J.R., Steward M.A. Bilateral inheritance as evidence for polygenicity in the hyperactive child syndrome. J Nerv Ment Dis. 158:1974;226-228.
77. Moss P.A.H., Davies K.E., Boni C., Mallet J., Reeders S.T. Linkage of tyrosine hydroxylase to four other markers on the short arm of chromosome 11. Nucleic Acids Res. 14:1986;9927-9932.
78. Muglia P., Jain U., Macciardi F., Kennedy J.L. Adult attention deficit hyperactivity disorder and the dopamine D4 receptor gene. Am J Med Genet. 96:2000;273-277.
79. Okuse K., Matsuoka I., Kurihara K. Tissue-specific methylation occurs in the essential promoter element of the tyrosine hydroxylase gene. Brain Res Mol Brain Res. 46(1-2):1997;197-207.
80. Palmer C.G., Bailey J.N., Ramsey C., Cantwell D., Sinsheimer J.S., Del'Homme M., McGough J., Woodward J.A., Asarnow R., Asarnow J., Nelson S., Smalley S.L. No evidence of linkage or linkage disequilibrium between DAT1 and attention deficit hyperactivity disorder in a large sample. Psychiatr Genet. 9(3):1999;157-160.
81. Papa M., Berger D.F., Sagvolden T., Sergeant J.A., Sadile A.G. A quantitative cytochrome oxidase mapping study, cross-regional and neurobehavioural correlations in the anterior forebrain of an animal model of attention deficit hyperactivity disorder. Behav Brain Res. 94(1):1998;197-211.
82. Payton A., Holmes J., Barrett J.H., Hever T., Fitzpatrick H., Trumper A.L., Harrington R., McGuffin P., O'Donovan M., Owen M., Ollier W., Worthington J., Thapar A. Examining for association between candidate gene polymorphisms in the dopamine pathway and attention-deficit hyperactivity disorder. a family-based study Am J Med Genet. 105(5):2001;464-470.
83. Randrup A., Scheel-Kruger J. Dietyldithiocarbanate and stereotyped behaviour. J Pharmacol. 18(11):1966;752.
84. Roman T., Schmitz M., Polanczyk G., Eizirik M., Rohde L.A., Hutz M.H. Attention-deficit hyperactivity disorder. a study of association with both the dopamine transporter gene and the dopamine D4 receptor gene Am J Med Genet. 105(5):2001;471-478.
85. Rowe D.C., Stever C., Giendinghagen L.N., Gard J.M.C., Cleveland H.H., Terris S.T., Mohr J.H., Shermans S., Abramowitz A., Waldman I.D. Dopamine DRD4 receptor polymorphism and attention deficit hyperactivity disorder. Mol Psychiatry. 3:1998;419-426.
86. Rowe D.C., den Oord E.J., Stever C., Giedinghagen L.N., Gard J.M., Cleveland H.H., Gilson M., Terris S.T., Mohr J.H., Sherman S., Abramowitz A., Waldman I.D. The DRD2 Taq 1 polymorphism and symptoms of attention deficit hyperactivity disorder. Mol Psychiatry. 4(6):1999;580-586.
87. Rubia K, Overmeyer S, Taylor E, Bullmore E, Brammer M, Williams S, Simmons A, Andrew C (1997): Inhibitory control of hyperactive adolescents in fMRI. In Toga AW, Frackowiak RSJ, Mazziotta JC (eds), Neuroimage. Third International Conference on Functional Mapping of the Human Brain (May 19-23, Copenhagen, Denmark). New York, Academic Press
88. Russell V., de Villiers A., Sagvolden T., Lamm M., Taljaard J. Altered dopaminergic function in the prefrontal cortex, nucleus accumbens and caudate-putamen of an animal model of attention-deficit hyperactivity disorder. the spontaneously hypertensive rat Brain Res. 676(2):1995;343-351.
89. Russell V.A. The nucleus accumbens motor-limbic interface of the spontaneously hypertensive rat as studied in vitro by the superfusion slice technique. Neurosci Biobehav Rev. 24(1):2000;133-136.
90. Schneider J.S., Roeltgen D.P. Delayed matching-to-sample, object retrieval, and discrimination reversal deficits in chronic low dose MPTP-treated monkeys. Brain Res. 615(2):1993;351-354.
91. Seeman P., Madras B.K. Anti-hyperactivity medication. methylphenidate and amphetamine Mol Psychiatry. 3:1998;386-396.
92. Sherrington R., Mankoo B., Dixon M., Curtis D., Kalsi G., Melmer G., Gurling H. Microsatellite polymorphisms for chromosome 5 bands q11.2-q13.3. Hum Hered. 43:1993;197-202.
93. Silberg J., Rutter M., Meyer J., Maes H., Hewitt J., Simonoff E., Pickles A., Loeber R., Eaves L. Genetic and environmental influences on the covariation between hyperactivity and conduct disturbance in juvenile twins. J Child Psychol Psychiatry. 37:1996;803-816.
94. Smalley S.L., Bailey J.N., Palmer C.G., Cantwell D.P., McGough J.J., Del'Homme M.A., Asarnow J.R., Woodward J.A., Ramsey C., Nelson S.F. Evidence that the dopamine D4 receptor is a susceptibility gene in attention deficit. Mol Psychiatry. 3:1998;427-430.
95. Speight G., Turic D., Austin J., Hoogendoorn B., Cardno A.G., Jones L., Murphy K.C., Sanders R., McCarthy G., Jones I., McCandless F., McGuffin P., Craddock N., Owen M.J., Buckland P., O'Donovan M.C. Comparative sequencing and association studies of aromatic L-amino acid decarboxylase in schizophrenia and bipolar disorder. Mol Psychiatry. 5(3):2000;327-331.
96. Spielman R.S., Ewens W.J. The TDT and other family-based tests for linkage disequilibrium and association. Am J Hum Gen. 59:1996;983-989.
97. Spurlock G., Williams J., McGuffin P., Aschauer H.N., Lenzinger E., Fuchs K., Sieghart W.C., Meszaros K., Fathi N., Laurent C., Mallet J., Macciardi F., Pedrini S., Gill M., Hawi Z., Gibson S., Jazin E.E., Yang H.T., Adolfsson R., Pato C.N., Dourado A.M., Owen M.J. European Multicentre Association Study of Schizophrenia. a study of the DRD2 Ser311Cys and DRD3 Ser9Gly polymorphisms Am J Med Genet. 81(1):1998;24-28.
98. Sunohara G.A., Roberts W., Malone M., Schachar R.J., Tannock R., Basile V.S., Wigal T., Wigal S.B., Schuck S., Moriarty J., Swanson J.M., Kennedy J.L., Barr C.L. Linkage of the dopamine D4 receptor gene and attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry. 39(12):2000;1537-1542.
99. Suarez B.K., Hampe C.L., Van Eerdewegh P. Problems of replicating linkage claims in psychiatry. Gershon E.S., Cloninger C.R., Barrett J.E. Genetic Approaches in Mental Disorders. 1998;23-46 American Psychiatric Press, Washington, DC.
100. Swanson J.M., Sergeant J.A., Taylor E., Sonuga-Barke E.J.S., Jensen P.S., Cantwell D.P. Attention-deficit hyperactivity disorder and hyperkinetic disorder. Lancet. 351:1998;429-433. a.
101. Swanson J.M., Sunohara G.A., Kennedy J.L., Regino R., Fineberg E., Wigal T., Lerner M., Williams L., LaHoste G.J., Wigal S. Association of the dopamine receptor D4 (DRD4) gene with a refined phenotype of attention deficit hyperactivity disorder (ADHD). a family-based approach Mol Psychiatry. 3(1):1998;38-41. b.
102. Swanson J., Castellanos F.X., Murias M., LaHoste G., Kennedy J. Cognitive neuroscience of attention deficit hyperactivity disorder and hyperkinetic disorder. Cur Opin Neurobiol. 8:1998;263-271. c.
103. Swanson J.M., Flodman P., Kennedy J., Spence M.A., Moyzis R., Schuck S., Murias M., Moriarity J., Barr C., Smith M., Posner M. Dopamine genes and ADHD. Neurosci Biobehav Rev. 24:2000;21-25.
104. Tahir E., Yazgan Y., Cirakoglu B., Ozbay F., Waldman I., Asherson P.J. Association and linkage of DRD4 and DRD5 with attention deficit hyperactivity disorder (ADHD) in a sample of Turkish children. Mol Psychiatry. 5(4):2000;396-404. a.
105. Tahir E., Curran S., Yazgan Y., Ozbay F., Cirakoglu B., Asherson P.J. No association between low- and high-activity catecholamine-methyl-transferase (COMT) and attention deficit hyperactivity disorder (ADHD) in a sample of Turkish children. Am J Med Genet. 96:2000;285-288. b.
106. Tannock R. Attention deficit hyperactivity disorder. advances in cognitive, neurobiological and genetic research J Child Psychol Psychiatr. 39(1):1998;65-99.
107. Terwilliger J.D., Ott J. A haplotype-based 'haplotype relative risk' approach to detecting allelic transmissions. Hum Hered. 42:1992;337-346.
108. Thapar A., Hervas A., McGuffin P. Childhood hyperactivity scores are highly heritable and show sibling competition effects. twin study evidence Behav Genet. 25:1995;537-544.
109. Thapar A., Holmes J., Poulton K., Harrington R. Genetic basis of attention deficit and hyperactivity. Br J Psychiatry. 174:1999;105-111.
110. Todd R.D. Genetics of attention deficit/hyperactivity disorder. are we ready for molecular genetic studies? Am J Med Genet. 96(3):2000;241-243.
111. Todd R.D., Neuman R.J., Lobos E.A., Jong Y.J., Reich W., Heath A.C. Lack of association of dopamine D4 receptor gene polymorphisms with ADHD subtypes in a population sample of twins. Am J Med Genet. 105(5):2001;432-438.
112. van Schothorst E.M., Jansen J.C., Bardoel A.F., van der Mey A.G., James M.J., Sobol H., Weissenbach J., van Ommen G.J., Cornelisse C.J., Devilee P. Confinement of PGL, an imprinted gene causing hereditary paragangliomas, to a 2-cM imterval on 11q22-q23 and exclusion of DRD2 and NCAM as candidate genes. Eur J Hum Genet. 4(5):1996;267-273.
113. Volkow N.D., Wang G.J., Fowler J.S., Gatley S.J., Logan J., Ding Y.S., Hitzemann R., Pappas N. Dopamine transporter occupancies in the human brain induced by therapeutic doses of oral methylphenidate. Am J Psychiatry. 155:1998;1325-1331.
114. Waldman I.D., Rowe D.C., Abramowitz A., Kozel S.T., Mohr J.H., Sherman S.L., Cleveland H.H., Sanders M.L., Gard J.M.C., Stever C. Association and linkage of the dopamine transporter gene and attention-deficit hyperactivity disorder in children. heterogeneity owing to diagnostic subtype and severity Am J Hum Genet. 63:1998;1767-1776.
115. Ward M.F., Wender P.H., Reimherr F.W. The Wender Utah Rating Scale. An aid in the retrospective diagnosis of childhood attention deficit hyperactivity disorder Am J Psychiatry. 150(6):1993;885-890.
116. Weiss G., Hechtman L.T. Hyperactive Children Grown Up. 1986;Guildford, New York.
117. Wilson M.C. Coloboma mouse mutant as an animal model of hyperkinesis and attention deficit hyperactivity disorder. Neurosci Behav Rev. 24:2000;51-55.
118. Zametkin A.J., Rapoport J.L. Noradrenergic hypothesis of attention deficit disorder with hyperactivity. A critical review Meltzer H.Y. Psychopharmacology. The Third Generation of Progress:1987;837-842 Raven Press, New York.
119. Zametkin A.J., Nordahl T.E., Gross J., King C.A., Semple W.E., Rumsey J., Hamberger M.A., Cohen R.M. Cerebral glucose metabolism in adults with hyperactivity of childhood onset. N Engl J Med. 323:1990;1361-1366.